Repair Stem Cell Institute Weighs in on Reversal of Embryonic Stem C... ( The Chairman...)

Repair Stem Cell Institute Weighs in on Reversal of Embryonic Stem Cell Policy

Date:3/12/2009

The Chairman of the Repair Stem Cell Institute says the viability of Embryonic Stem Cells is an Illusion. Repair (Adult) Stem Cells have swept to such a large lead in diseases being treated all over the world, that it will be impossible for embryonic stem cell research, with all the insurmountable problems, to catch up -- ever.

Bangkok (PRWEB) March 12, 2009 -- Don Margolis, the retired founder of the world's first adult stem cell treatment company and chairman of the Repair Stem Cell Institute (RSCI), today issued a statement from RSCI headquarters in Bangkok, Thailand, in response to President Obama's reversal of current U.S. policy on stem cell research. In it, Margolis said that "Science itself will destroy the illusion of the viability of embryonic stem cells."

Adult Stem Cells have already been proven to safely treat and improve the quality of life for thousands of patients, with successful treatments for multiple sclerosis, heart conditions, optic nerve disorders, diabetes and 100+ other treatable conditions.

Margolis went on to explain "There are six reasons why Embryonic Stem Cells will never make it out of the lab and into the bodies of sick Americans."

Reason one, there is no need for still-useless embryonics. "We already have Repair (Adult) Stem Cells, the most powerful medicine the world has ever seen, capable now of improving the quality of life of millions of patients; something embryonics will never even approach, let alone reach.

Second, no scientist in the world, not just America, has a clue on how to stop the inevitable cancer threat of ESC.

Third, our bodies are built to
'/>"/>

0

GOOD

Page: 1 2
Related biology technology :

1. GYNECARE PROLIFT+M(TM) Pelvic Floor Repair System Launched in US for Use in Pelvic Organ Prolapse Surgery
2. Biomerix Corporation Announces FDA Clearance and Market Launch of REVIVE(TM) for Use in Soft Tissue Repair Procedures
3. Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair
4. BioSyntech Achieves Enrolment Goal for Pivotal Trial of BST-CarGel(R), its Cartilage Repair Device
5. Positive Preclinical Data on Cell Therapy for Spinal Disc Repair Presented at 23rd Annual Meeting of the North American Spine Society
6. California State Senator Shelia Kuehls Leadership in Stem Cell Debate Praised and Embryonic Stem Cell Profiteers Criticized by Repair Stem Cell Institute Spokesman
7. Stem Cell Profits Five Years Away, Says Repair Stem Cell Institute Chairman to The Wall Street Transcript
8. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
9. Repair Stem Cell Institute Announces Science Advisory Board
10. Worldwide Center for Adult Stem Cell Education LLC Changes Name to The Repair Stem Cell Institute LLC
11. Real-time observation of the DNA-repair mechanism

Post Your Comments:

Repair Stem Cell Institute Weighs in on Reversal of Embryonic Stem C...( The Chairman...)